Caricamento...
Host MyD88 signaling protects against acute graft‐versus‐host disease after allogeneic bone marrow transplantation
Recent experimental strategies to reduce graft‐versus‐host disease (GVHD) have focused largely on modifying innate immunity. Toll‐like receptor (TLR)‐driven myeloid differentiation primary response 88 (MyD88)‐dependent signalling pathways that initiate adaptive immune function are also critical for...
Salvato in:
| Pubblicato in: | Clin Exp Immunol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6300651/ https://ncbi.nlm.nih.gov/pubmed/30317551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13215 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|